- CA$300.17m
- CA$252.95m
- $16.10m
Brief: Profound Medical Announces Second Quarter 2022 Financial Results
Brief: Profound Medical Clarifies Recent Insider Buying
Canada Research Roundup: Artis REIT, Bank of Montreal, Sleep Country Canada Holdings
Brief: Profound Medical Announces Q4 And Full Year 2021 Financial Results
Brief: Profound Medical'S Tulsa-Pro Now Compatible With GE Healthcare's 3T MRI Scanners
Brief: Profound Medical Reports Q2 2021 Financial Results
U.S. STOCKS ON THE MOVE-Evoke Pharma, American Well, Perrigo
Brief: Profound Medical Reports Q1 Loss Per Share $0.37
Brief: Akumin And Profound Medical Enter U.S. Multi-Center Commercial Agreement For Tulsa-Pro
Brief: Profound Medical Posts Q4 Revenue Of About $2.9 Mln
Brief: Profound Medical Announces Preliminary Unaudited Fourth Quarter And Full Year 2020 Revenues
Brief: Profound Medical Signs Agreement With GE Healthcare To Expand Provider Access To Tulsa-Pro
Brief: Profound Medical Announces Changes To Its Board Of Directors
Brief: Profound Medical Corp Says Qtrly Net Loss Per Share $0.43
Brief: Profound Medical Announces Second Quarter 2020 Financial Results
Brief: Profound Medical Announces Pricing Of Offering Of Common Shares
Brief: Profound Medical Announces Proposed Offering Of Common Shares
Canada Stocks: TSX futures down on fears of second coronavirus wave
Canada Research Roundup: Artis REIT, Constellation Software, SNC-Lavalin Group